Home Cart 0 Sign in  
X

[ CAS No. 337958-60-8 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 337958-60-8
Chemical Structure| 337958-60-8
Chemical Structure| 337958-60-8
Structure of 337958-60-8 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 337958-60-8 ]

Related Doc. of [ 337958-60-8 ]

Alternatived Products of [ 337958-60-8 ]

Product Details of [ 337958-60-8 ]

CAS No. :337958-60-8 MDL No. :MFCD11518965
Formula : C8H4Cl2N2 Boiling Point : -
Linear Structure Formula :- InChI Key :HNRPBMNTCYRAJD-UHFFFAOYSA-N
M.W : 199.04 Pubchem ID :12204233
Synonyms :

Calculated chemistry of [ 337958-60-8 ]

Physicochemical Properties

Num. heavy atoms : 12
Num. arom. heavy atoms : 10
Fraction Csp3 : 0.0
Num. rotatable bonds : 0
Num. H-bond acceptors : 2.0
Num. H-bond donors : 0.0
Molar Refractivity : 49.56
TPSA : 25.78 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.36 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.95
Log Po/w (XLOGP3) : 3.04
Log Po/w (WLOGP) : 2.94
Log Po/w (MLOGP) : 2.03
Log Po/w (SILICOS-IT) : 3.21
Consensus Log Po/w : 2.63

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -3.61
Solubility : 0.0493 mg/ml ; 0.000248 mol/l
Class : Soluble
Log S (Ali) : -3.25
Solubility : 0.113 mg/ml ; 0.000566 mol/l
Class : Soluble
Log S (SILICOS-IT) : -4.57
Solubility : 0.00542 mg/ml ; 0.0000272 mol/l
Class : Moderately soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.6

Safety of [ 337958-60-8 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P280-P305+P351+P338-P310 UN#:N/A
Hazard Statements:H302-H315-H319-H332-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 337958-60-8 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 337958-60-8 ]
  • Downstream synthetic route of [ 337958-60-8 ]

[ 337958-60-8 ] Synthesis Path-Upstream   1~4

  • 1
  • [ 1345461-33-7 ]
  • [ 337958-60-8 ]
Reference: [1] Patent: WO2011/134971, 2011, A1, . Location in patent: Page/Page column 15; 16; 71; 72
[2] Patent: US2013/40984, 2013, A1, . Location in patent: Paragraph 0476-0477
  • 2
  • [ 927-63-9 ]
  • [ 1345456-45-2 ]
  • [ 337958-60-8 ]
YieldReaction ConditionsOperation in experiment
0.42 g
Stage #1: With n-butyllithium In tetrahydrofuran; hexane at -70 - -60℃; for 1.5 h; Inert atmosphere
Stage #2: at -70 - 20℃; for 0.833333 h; Inert atmosphere
Intermediate 7: 5,7-Dichloro-1,6-naphthyridine[0384]N-(2,6-Dichloro-4-pyridinyl)-2,2-dimethylpropanamide (1 g, 4.05 mmol) was taken up in THF (10 ml) under nitrogen and cooled to n-Butyl lithium (4.05 ml, 10.12 mmol, 2.5M solution in hexanes) was added over 30 min keeping the temperature below −60° C. and then stirred at below −70° C. for 1 h. (2E)-3-(dimethylamino)-2-propenal (0.607 ml, 6.07 mmol) in THF (2 ml) was added over 30 min keeping the temperature below −60° C. The reaction was stirred at below −70° C. for 20 min and then allowed to warm to room temperature. LCMS showed that no starting material remained so the reaction was quenched with 5M HCl (5 ml) and refluxed overnight. LCMS showed good conversion to product so the reaction was cooled to room temperature. The reaction mixture was basified with solid K2CO3 and extracted with EtOAc (4×25 ml). The combined organics were dried with Na2SO4, filtered and concentrated to yield a brown solid. The crude product was applied to a samplet and columned using a 40+M eluting with 12percent diethyl ether in cyclohexane for 2 CVs, then with 12percent-63percent diethyl ether in cyclohexane over 10 CVs then held at 63percent for SCVs. Appropriate fractions were combined and evaporated to give the title compound as a yellow solid (0.42 g).[0386]LCMS (Method B): Rt=0.89 min, MH+ 199/201
Reference: [1] Patent: WO2011/134971, 2011, A1, . Location in patent: Page/Page column 12; 13; 53; 54
[2] Patent: US2013/40984, 2013, A1, . Location in patent: Paragraph 0384-0386
  • 3
  • [ 2942-59-8 ]
  • [ 337958-60-8 ]
Reference: [1] Patent: WO2011/134971, 2011, A1,
[2] Patent: US2013/40984, 2013, A1,
  • 4
  • [ 2587-02-2 ]
  • [ 337958-60-8 ]
Reference: [1] Patent: WO2011/134971, 2011, A1,
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 337958-60-8 ]

Chlorides

Chemical Structure| 23616-32-2

[ 23616-32-2 ]

5-Chloro[1,6]naphthyridine

Similarity: 0.86

Chemical Structure| 59412-12-3

[ 59412-12-3 ]

2,5-Dichloroquinoline

Similarity: 0.79

Chemical Structure| 80947-25-7

[ 80947-25-7 ]

2-Chloroquinolin-4-amine

Similarity: 0.79

Chemical Structure| 952138-13-5

[ 952138-13-5 ]

4,7-Dichloro-1,6-naphthyridine

Similarity: 0.78

Chemical Structure| 1810-72-6

[ 1810-72-6 ]

2,6-Dichloroquinoline

Similarity: 0.77

Related Parent Nucleus of
[ 337958-60-8 ]

Naphthyridines

Chemical Structure| 23616-32-2

[ 23616-32-2 ]

5-Chloro[1,6]naphthyridine

Similarity: 0.86

Chemical Structure| 952138-13-5

[ 952138-13-5 ]

4,7-Dichloro-1,6-naphthyridine

Similarity: 0.78

Chemical Structure| 931100-02-6

[ 931100-02-6 ]

4,6,8-Trichloro-1,7-naphthyridine

Similarity: 0.74

Chemical Structure| 107484-69-5

[ 107484-69-5 ]

5-Chloro-8-iodo-1,6-naphthyridine

Similarity: 0.70

Chemical Structure| 253-72-5

[ 253-72-5 ]

1,6-Naphthyridine

Similarity: 0.67